• Julia Yang is President/Co-Founder of Medical Global Alliance (MGA). MGA brings medical technology cross borders between US/EU and China/Asia, providing strategic assistance to foreign companies entering the China/Asia market and supporting China/Asia companies globally.
• Pharmaceutical/Medical Device Physician Executive with 20 years managerial experience in Global Clinical Research & Drug Development and Global Medical Affairs across multiple therapeutic areas (Cardiovascular, Endocrinology, Neurology, Critical Care, etc).
• Proven track record in leading global clinical programs (Phase I-IV and life cycle management) leading to New Drug Application NDA submissions, worldwide drug approvals and successful product launches globally (Fycompa® for seizures, and Praluent® for lipid lowering/cardiovascular).

Education/Background:

• Julia graduated from Tianjin Medical University (M.D.)
• MBA, California Lutheran University, USA.
• Trained as an ear, nose, throat, head and neck surgeon.
• Clinical Fellowships from Johns Hopkins School of Medicine and Mayo Clinic.
• Previously worked with Sanofi, Baxter, Medtronic, Eisai and Amgen.
• Received Presidential and multiple honorable awards for outstanding achievements.
• Invited as Honorable Speaker and Industry Expert at international congresses for drug development/clinical trial management.